MyChesCo on MSN

J&J’s lupus breakthrough sets the stage for a high-stakes phase 3 push

SPRING HOUSE, PA — Johnson & Johnson (NYSE: JNJ) said its experimental immune therapy nipocalimab cleared a major clinical ...
inews.co.ukOpinion

Trump and Putin are threatening the UK’s backyard – here’s how it can be defended

A new world of great power competition and gunboat diplomacy threatens to turn the Arctic into a military hot zone – meaning ...

YouTube-famous investor sells Griffin Farm retail center in Lake Mary

A prominent real estate investor and YouTube personality is shifting his company's strategy back to multifamily properties, ...

A rash of Baltic cable-cutting raises fears of sabotage

A few days earlier, on December 31st, Finnish authorities seized a cargo ship suspected of damaging two communication cables between Finland and Estonia ...
TAPinto

St. Gerard Majella Students Celebrate Three Kings Day with Toys, Blessings, and a Visit From the Mayor

PATERSON, NJ - Over 100 students at St. Gerard Majella School celebrated Three Kings Day with gifts, prayers, and a special ...
Applied Clinical Trials Online

Nipocalimab Delivers Positive Phase IIb Results in JASMINE SLE Trial

The JASMINE trial showed nipocalimab's efficacy in SLE, meeting primary and secondary endpoints, including steroid sparing ...

Johnson & Johnson unveils new data showing nipocalimab is the first and only investigational FcRn blocker with potential to reduce systemic lupus erythematosus (SLE) activity ...

Johnson & Johnson (NYSE: JNJ) today announced positive topline results from the Phase 2b JASMINE (NCT04882878) study of adults living with systemic lupus erythematosus (SLE) and the initiation of a ...
TAPinto

Paterson to Get its First Pickleball Court Thanks to 100K Donation

PATERSON, NJ - A historic new recreational opportunity is coming to Paterson thanks to a $100,000 donation from Veloce ...